ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,602, issued on April 21, was assigned to OSLO UNIVERSITETSSYKEHUS HF (Nydalen, Norway).
"Recombinant CCN domain proteins and fusion proteins" was invented by Havard Attramadal (Hobol, Norway) and Ole Jorgen Kaasboll (Oslo, Norway).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to recombinant proteins having an amino acid sequence corresponding to or related to the thrombospondin type 1 repeat homology domain of a member of the CCN family proteins and the use thereof. Furthermore, the present invention relates to fusion proteins comprising an amino acid sequence corresponding to or related to the thrombospondin type 1 re...